Published in Am J Obstet Gynecol on December 27, 2011
Periconceptional folic acid associated with an increased risk of oral clefts relative to non-folate related malformations in the Northern Netherlands: a population based case-control study. Eur J Epidemiol (2013) 1.45
SOD1 suppresses maternal hyperglycemia-increased iNOS expression and consequent nitrosative stress in diabetic embryopathy. Am J Obstet Gynecol (2012) 1.00
Superoxide dismutase 1 overexpression in mice abolishes maternal diabetes-induced endoplasmic reticulum stress in diabetic embryopathy. Am J Obstet Gynecol (2013) 0.99
Genetic, epigenetic, and environmental contributions to neural tube closure. Annu Rev Genet (2014) 0.99
Decoding the oxidative stress hypothesis in diabetic embryopathy through proapoptotic kinase signaling. Am J Obstet Gynecol (2014) 0.97
Oxidative stress is responsible for maternal diabetes-impaired transforming growth factor beta signaling in the developing mouse heart. Am J Obstet Gynecol (2015) 0.93
Advances in revealing the molecular targets downstream of oxidative stress-induced proapoptotic kinase signaling in diabetic embryopathy. Am J Obstet Gynecol (2015) 0.93
Nongenetic risk factors and congenital heart defects. Pediatr Cardiol (2013) 0.90
Curcumin ameliorates high glucose-induced neural tube defects by suppressing cellular stress and apoptosis. Am J Obstet Gynecol (2015) 0.88
The impact of folic acid intake on the association among diabetes mellitus, obesity, and spina bifida. Am J Obstet Gynecol (2013) 0.88
Changes in the Incidence of Congenital Anomalies in Henan Province, China, from 1997 to 2011. PLoS One (2015) 0.86
Folic acid supplementation in pregnancy and implications in health and disease. J Biomed Sci (2014) 0.84
Failing to prevent birth defects caused by maternal diabetes mellitus. Am J Obstet Gynecol (2011) 0.82
Dominant negative FADD dissipates the proapoptotic signalosome of the unfolded protein response in diabetic embryopathy. Am J Physiol Endocrinol Metab (2015) 0.82
Modeling anterior development in mice: diet as modulator of risk for neural tube defects. Am J Med Genet C Semin Med Genet (2013) 0.81
Risk of birth defects associated with maternal pregestational diabetes. Eur J Epidemiol (2014) 0.81
Diabetes and congenital heart defects: a systematic review, meta-analysis, and modeling project. Am J Prev Med (2014) 0.81
Type 2 diabetes mellitus induces congenital heart defects in murine embryos by increasing oxidative stress, endoplasmic reticulum stress, and apoptosis. Am J Obstet Gynecol (2016) 0.80
Joint effects of genetic variants and residential proximity to pesticide applications on hypospadias risk. Birth Defects Res A Clin Mol Teratol (2016) 0.80
The green tea polyphenol EGCG alleviates maternal diabetes-induced neural tube defects by inhibiting DNA hypermethylation. Am J Obstet Gynecol (2016) 0.78
Levonorgestrel in cases of rape: How does it work? Linacre Q (2014) 0.78
High glucose-induced oxidative stress represses sirtuin deacetylase expression and increases histone acetylation leading to neural tube defects. J Neurochem (2016) 0.77
Obstructive heart defects associated with candidate genes, maternal obesity, and folic acid supplementation. Am J Med Genet A (2015) 0.75
Elevated body mass index and decreased diet quality among women and risk of birth defects in their offspring. Birth Defects Res A Clin Mol Teratol (2015) 0.75
Screening high-risk clusters for developing birth defects in mothers in Shanxi Province, China: application of latent class cluster analysis. BMC Pregnancy Childbirth (2015) 0.75
Nonparametric Bayes modeling for case control studies with many predictors. Biometrics (2015) 0.75
Limitations of Aneuploidy and Anomaly Detection in the Obese Patient. J Clin Med (2014) 0.75
Proportion of selected congenital heart defects attributable to recognized risk factors. Ann Epidemiol (2016) 0.75
Appreciation for analysis of how levonorgestrel works and reservations with the use of meloxicam as emergency contraception. Linacre Q (2016) 0.75
Maternal exposures in the National Birth Defects Prevention Study: Time trends of selected exposures. Birth Defects Res A Clin Mol Teratol (2015) 0.75
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health. Obes Res (1998) 50.73
Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet (1991) 17.95
Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med (1992) 14.22
Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002. Diabetes Care (2006) 12.14
Calculating measures of biological interaction. Eur J Epidemiol (2005) 6.82
The National Birth Defects Prevention Study. Public Health Rep (2001) 5.50
Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Recomm Rep (1992) 4.22
Evaluating the quality of self-reports of hypertension and diabetes. J Clin Epidemiol (2003) 4.00
Guidelines for case classification for the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol (2003) 3.75
Diabetes mellitus and birth defects. Am J Obstet Gynecol (2008) 3.25
Trends in blood folate and vitamin B-12 concentrations in the United States, 1988 2004. Am J Clin Nutr (2007) 3.03
Elevated maternal hemoglobin A1c in early pregnancy and major congenital anomalies in infants of diabetic mothers. N Engl J Med (1981) 2.89
Seeking causes: Classifying and evaluating congenital heart defects in etiologic studies. Birth Defects Res A Clin Mol Teratol (2007) 2.69
Review of the performance of methods to identify diabetes cases among vital statistics, administrative, and survey data. Ann Epidemiol (2004) 2.58
Why don't women with diabetes plan their pregnancies? Diabetes Care (1998) 2.41
Reliability and validity of self-report of vitamin and mineral supplement use in the vitamins and lifestyle study. Am J Epidemiol (2003) 2.38
Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: a meta-analysis. QJM (2001) 2.34
Preconception care of diabetes. Glycemic control prevents congenital anomalies. JAMA (1991) 2.11
Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care. Diabetes Care (2008) 2.04
Diabetes trends among delivery hospitalizations in the U.S., 1994-2004. Diabetes Care (2010) 1.94
Control selection and participation in an ongoing, population-based, case-control study of birth defects: the National Birth Defects Prevention Study. Am J Epidemiol (2009) 1.93
Maternal diabetes mellitus and infant malformations. Obstet Gynecol (2002) 1.84
Vitamin supplements and the risk for congenital anomalies other than neural tube defects. Am J Med Genet C Semin Med Genet (2004) 1.79
Risk of minor and major fetal malformations in diabetics with high haemoglobin A1c values in early pregnancy. Br Med J (Clin Res Ed) (1984) 1.77
Folic acid supplementation and the occurrence of congenital heart defects, orofacial clefts, multiple births, and miscarriage. Am J Clin Nutr (2005) 1.77
Combined treatment with vitamin E and vitamin C decreases oxidative stress and improves fetal outcome in experimental diabetic pregnancy. Pediatr Res (2001) 1.68
Patterns of congenital anomalies and relationship to initial maternal fasting glucose levels in pregnancies complicated by type 2 and gestational diabetes. Am J Obstet Gynecol (2000) 1.53
Validity of methods used to assess vitamin and mineral supplement use. Am J Epidemiol (1998) 1.52
Pregnancy in women with Type 2 diabetes: 12 years outcome data 1990-2002. Diabet Med (2003) 1.50
Lipoic acid prevention of neural tube defects in offspring of rats with streptozocin-induced diabetes. Am J Obstet Gynecol (1999) 1.49
Activation of oxidative stress signaling that is implicated in apoptosis with a mouse model of diabetic embryopathy. Am J Obstet Gynecol (2008) 1.46
Maternal diabetes and cardiovascular malformations: predominance of double outlet right ventricle and truncus arteriosus. Teratology (1990) 1.26
Diabetes and pregnancy. Factors associated with seeking pre-conception care. Diabetes Care (1995) 1.24
Do multivitamin supplements attenuate the risk for diabetes-associated birth defects? Pediatrics (2003) 1.09
Folic acid supplementation diminishes diabetes- and glucose-induced dysmorphogenesis in rat embryos in vivo and in vitro. Diabetes (2005) 1.07
Multifactorial basis of the syndrome of diabetic embryopathy. Teratology (1996) 1.06
Correlates of intake of folic acid-containing supplements among pregnant women. Am J Obstet Gynecol (2006) 1.02
Vitamin E decreases the occurrence of malformations in the offspring of diabetic rats. Diabetes (1997) 0.99
Folic acid prevents congenital malformations in the offspring of diabetic mice. Endocr J (2008) 0.97
The role of free radicals and membrane lipids in diabetes-induced congenital malformations. J Soc Gynecol Investig (1998) 0.97
Antioxidative treatment of pregnant diabetic rats diminishes embryonic dysmorphogenesis. Birth Defects Res A Clin Mol Teratol (2005) 0.95
Maternal diabetes and congenital anomalies in South Australia 1986-2000: a population-based cohort study. Birth Defects Res A Clin Mol Teratol (2005) 0.93
Experimental mechanisms of diabetic embryopathy and strategies for developing therapeutic interventions. J Soc Gynecol Investig (2005) 0.92
Alpha-lipoic acid reduces congenital malformations in the offspring of diabetic mice. Diabetes Metab Res Rev (2009) 0.82
A diabetes-like environment increases malformation rate and diminishes prostaglandin E(2) in rat embryos: reversal by administration of vitamin E and folic acid. Birth Defects Res A Clin Mol Teratol (2005) 0.82
Pre-conception planning. The relationship's the thing. Diabetes Care (1998) 0.82
Central challenges facing the national clinical research enterprise. JAMA (2003) 17.41
The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? Genet Med (2007) 9.48
Cognitive and behavioral outcomes of school-aged children who were born preterm: a meta-analysis. JAMA (2002) 8.15
Maternal treatment with opioid analgesics and risk for birth defects. Am J Obstet Gynecol (2011) 4.14
National estimates and race/ethnic-specific variation of selected birth defects in the United States, 1999-2001. Birth Defects Res A Clin Mol Teratol (2006) 4.08
Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med (2007) 3.79
Guidelines for case classification for the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol (2003) 3.75
Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008. Am J Obstet Gynecol (2011) 3.42
Reporting birth defects surveillance data 1968-2003. Birth Defects Res A Clin Mol Teratol (2007) 3.29
Diabetes mellitus and birth defects. Am J Obstet Gynecol (2008) 3.25
Seeking causes: Classifying and evaluating congenital heart defects in etiologic studies. Birth Defects Res A Clin Mol Teratol (2007) 2.69
Antibacterial medication use during pregnancy and risk of birth defects: National Birth Defects Prevention Study. Arch Pediatr Adolesc Med (2009) 2.45
Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism. Am J Med Genet B Neuropsychiatr Genet (2006) 2.44
Prepregnancy obesity as a risk factor for structural birth defects. Arch Pediatr Adolesc Med (2007) 2.43
Assisted reproductive technology and major structural birth defects in the United States. Hum Reprod (2008) 2.38
Storage and use of residual dried blood spots from state newborn screening programs. J Pediatr (2006) 2.36
Maternal occupational exposure to organic solvents during early pregnancy and risks of neural tube defects and orofacial clefts. Occup Environ Med (2012) 2.35
Maternal obesity and risk for birth defects. Pediatrics (2003) 2.33
Research agenda for preterm birth: recommendations from the March of Dimes. Am J Obstet Gynecol (2005) 2.21
Evidence-based reproductive health care in Cameroon: population-based study of awareness, use and barriers. Bull World Health Organ (2006) 2.19
Maternal exposure to ambient levels of benzene and neural tube defects among offspring: Texas, 1999-2004. Environ Health Perspect (2010) 2.16
Use of topiramate in pregnancy and risk of oral clefts. Am J Obstet Gynecol (2012) 2.14
Sharing prescription medication among teenage girls: potential danger to unplanned/undiagnosed pregnancies. Pediatrics (2003) 1.99
Good and poor adherence: optimal cut-point for adherence measures using administrative claims data. Curr Med Res Opin (2009) 1.97
Tramadol HCL has promise in on-demand use to treat premature ejaculation. J Sex Med (2007) 1.96
GTF2I hemizygosity implicated in mental retardation in Williams syndrome: genotype-phenotype analysis of five families with deletions in the Williams syndrome region. Am J Med Genet A (2003) 1.94
Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States. Teratology (2002) 1.94
Alcohol consumption by women before and during pregnancy. Matern Child Health J (2008) 1.94
Control selection and participation in an ongoing, population-based, case-control study of birth defects: the National Birth Defects Prevention Study. Am J Epidemiol (2009) 1.93
The importance of nomenclature for congenital cardiac disease: implications for research and evaluation. Cardiol Young (2008) 1.92
Residential mobility patterns and exposure misclassification in epidemiologic studies of birth defects. J Expo Sci Environ Epidemiol (2006) 1.79
Differences in exposure assignment between conception and delivery: the impact of maternal mobility. Paediatr Perinat Epidemiol (2010) 1.76
Treatment of hyperthyroidism in pregnancy and birth defects. J Clin Endocrinol Metab (2010) 1.76
Reduced risks of neural tube defects and orofacial clefts with higher diet quality. Arch Pediatr Adolesc Med (2011) 1.73
Maternal exposure to methotrexate and birth defects: a population-based study. Am J Med Genet A (2014) 1.70
Neural tube defects and maternal folate intake among pregnancies conceived after folic acid fortification in the United States. Am J Epidemiol (2008) 1.69
Prevalence of birth defects among infants of Gulf War veterans in Arkansas, Arizona, California, Georgia, Hawaii, and Iowa, 1989-1993. Birth Defects Res A Clin Mol Teratol (2003) 1.68
Changes in the birth prevalence of selected birth defects after grain fortification with folic acid in the United States: findings from a multi-state population-based study. Birth Defects Res A Clin Mol Teratol (2005) 1.68
Association between pregnancy intention and reproductive-health related behaviors before and after pregnancy recognition, National Birth Defects Prevention Study, 1997-2002. Matern Child Health J (2009) 1.68
Specific SSRIs and birth defects: Bayesian analysis to interpret new data in the context of previous reports. BMJ (2015) 1.68
Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects. Birth Defects Res A Clin Mol Teratol (2011) 1.66
Creating a new structure for research on health care effectiveness. J Investig Med (2005) 1.64
PKC-delta and -eta, MEKK-1, MEK-6, MEK-3, and p38-delta are essential mediators of the response of normal human epidermal keratinocytes to differentiating agents. J Invest Dermatol (2010) 1.64
An empirical basis for standardizing adherence measures derived from administrative claims data among diabetic patients. Med Care (2008) 1.63
Maternal asthma medication use and the risk of gastroschisis. Am J Epidemiol (2008) 1.62
Effect of an intraoperative double-gloving strategy on the incidence of cerebrospinal fluid shunt infection. J Neurosurg (2006) 1.62
Improvement in stroke mortality in Canada and the United States, 1990 to 2002. Circulation (2006) 1.58
Orofacial clefts in the National Birth Defects Prevention Study, 1997-2004. Am J Med Genet A (2009) 1.55
Ambient air pollution and cardiovascular malformations in Atlanta, Georgia, 1986-2003. Am J Epidemiol (2009) 1.54
Prevalence in the United States of selected candidate gene variants: Third National Health and Nutrition Examination Survey, 1991-1994. Am J Epidemiol (2008) 1.53
Applying public health strategies to primary immunodeficiency diseases: a potential approach to genetic disorders. MMWR Recomm Rep (2004) 1.52
Mortality in achondroplasia study: a 42-year follow-up. Am J Med Genet A (2007) 1.49
Maternal smoking and congenital heart defects. Pediatrics (2008) 1.49
An outcomes analysis of over 200 revision surgeries for penile prosthesis implantation: a multicenter study. J Sex Med (2011) 1.47
Genetic epidemiology and congenital malformations: from the chromosome to the crib. Arch Pediatr Adolesc Med (2002) 1.46
A clarion call for translational and collaborative research. Am J Obstet Gynecol (2006) 1.46
Activation of oxidative stress signaling that is implicated in apoptosis with a mouse model of diabetic embryopathy. Am J Obstet Gynecol (2008) 1.46
Maternal hypertension, medication use, and hypospadias in the National Birth Defects Prevention Study. Obstet Gynecol (2014) 1.45
Perineal approach for artificial urinary sphincter implantation appears to control male stress incontinence better than the transscrotal approach. J Urol (2008) 1.44
Antidepressant Prescription Claims Among Reproductive-Aged Women With Private Employer-Sponsored Insurance - United States 2008-2013. MMWR Morb Mortal Wkly Rep (2016) 1.43
Is the intrapartum biophysical profile useful? Obstet Gynecol (2003) 1.41
Antiherpetic medication use and the risk of gastroschisis: findings from the National Birth Defects Prevention Study, 1997-2007. Paediatr Perinat Epidemiol (2013) 1.40
Maternal butalbital use and selected defects in the national birth defects prevention study. Headache (2013) 1.39
Using bayesian models to assess the effects of under-reporting of cannabis use on the association with birth defects, national birth defects prevention study, 1997-2005. Paediatr Perinat Epidemiol (2014) 1.39
Association between prepregnancy body mass index and congenital heart defects. Am J Obstet Gynecol (2009) 1.38
A survey of patients with inflatable penile prostheses: assessment of timing and frequency of intercourse and analysis of implant durability. J Sex Med (2012) 1.38
Long-term survival of inflatable penile prostheses: single surgical group experience with 2,384 first-time implants spanning two decades. J Sex Med (2007) 1.37
A guide for inflatable penile prosthesis reservoir placement: pertinent anatomical measurements of the retropubic space. J Sex Med (2013) 1.37
Congenital malformations among liveborn infants with trisomies 18 and 13. Am J Med Genet A (2006) 1.36
Ethnicity, sex, and the incidence of congenital heart defects: a report from the National Down Syndrome Project. Genet Med (2008) 1.36
The National Down Syndrome Project: design and implementation. Public Health Rep (2007) 1.35